Life Science Investments - Schedule of Carrying Value of Investments (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Schedule of Equity Method Investments [Line Items] | ||
| PIK dividend | $ 2,220 | $ 444 |
| PIK interest | 1,163 | 415 |
| Total | 275,888 | 152,665 |
| Investment in IQHQ Credit Facility | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Investment in IQHQ Credit Facility | 97,121 | 96,493 |
| Investment in IQHQ Preferred Stock | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Life science investments | 159,730 | 47,430 |
| Investment in IQHQ Warrant | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Life science investments | 15,654 | 5,321 |
| Forward contract for the purchase of IQHQ Preferred Stock | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Life science investments | $ 0 | $ 2,562 |
| X | ||||||||||
- Definition Financing Receivable, after Allowance for Credit Loss, Net No definition available.
|
| X | ||||||||||
- Definition Other Investments, Net No definition available.
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of dividends declared but not received. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|